tirzepatide surpass cvot Diabetes Distilled: SURPASS-CVOT – demonstrates cardiovascular benefit in secondary prevention 🫀 EASD 2025: Tirzepatide (SURPASS-CVOT)

Focus on balanced mealsthe goal is fueling at the right level, not continuing to reduce

The malignant potential of congenital nevi may be dependent on the histologic pattern of the lesion rather than the clinical size

Mounjaro has shown potential for greater weight loss in certain studies, but Ozempic has also been approved to lower the risk of stroke and heart failure in addition to treating Type 2 diabetes

The typical sequence of symptoms is present in about 50% of cases

Explain What's Happening Inside the Body (Weeks 28) Many patients don't realize that body composition changes before they notice major visual differences

We provide the full spectrum of care-from initial medical assessment and lab review to prescription management and ongoing virtual follow-ups-all through a secure online platform